BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 3, 2022
View Archived Issues
Tyrosine kinase inhibitor NTRC-0652-0 shows promise for the treatment of cholangiocarcinoma
Read More
New prolyl endopeptidase inhibitors identified at Accure Therapeutics
Read More
ReViral describes new compounds for respiratory syncytial virus infections
Read More
Mcl-1 inhibitors discovered at Janssen
Read More
3M Innovative Properties divulges new Toll-like receptor 7 agonists
Read More
Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent Bcl-2 and/or Bcl-X inhibitors
Read More
Endothelial BCAR1 expression associated with antiangiogenic therapy resistance
Read More
Discovery of novel MBL inhibitors as promising beta-lactam antibiotics
Read More
Epigenetic-mediated immune mechanisms identified in TB
Read More
A microbiota-macrophage-iron axis regulates hematopoietic stem cell fate decisions under stress
Read More
A comprehensive catalog of functional cell types and cellular states in human brain metastases
Read More
Targeting PPARalpha-ACOT12 axis as a potential new therapeutic strategy for osteoarthritis
Read More
PLA2-IIA modulates immunity through its interaction with microbiota
Read More
CIRM grant supports Juvena's preclinical work on JUV-161 for myotonic dystrophy type 1
Read More
Brickell licenses rights to Carna's STING antagonists for autoimmune and inflammatory diseases
Read More
Anakuria's AT-20494 to be studied for ADPKD and other indications
Read More